Beth Seidenberg, Director, Ten Percent Owner at Latigo Biotherapeutics, Inc., holds 2.09M shares in Latigo Biotherapeutics, Inc. (Ticker: LTGO), holds 4.68M shares in Kyverna Therapeutics, Inc. (Ticker: KYTX), holds 0.00 shares in ACELYRIN, INC. (Ticker: SLRN).
Beth Seidenberg latest transaction was an Uninformative Buy of ―.
What was Beth Seidenberg's most profitable transaction?
Beth Seidenberg’s most profitable transaction was an Informative Buy of ATRA stock on October 15, 2014. The return on the trade was 800.00%.
What is Beth Seidenberg's role in Latigo Biotherapeutics, Inc.?
Beth Seidenberg's role in Latigo Biotherapeutics, Inc. is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.